Get started
Biotest AGBiotest AGBiotest AG

Biotest AG

No trades
See on Supercharts
Overview
Financials Discussions Seasonals

BIO chart


Full chart

Key stats


Market capitalization
‪1.37 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.620 EUR
Net income (FY)
‪26.40 M‬ EUR
Revenue (FY)
‪726.20 M‬ EUR
Shares float
‪565.87 K‬
Beta (1Y)
−0.22

Employees


Employees (FY)
‪2.5 K‬
Change (1Y)
+69 +2.84%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Biotest AG


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Jörg Schüttrumpf
Website
biotest.de
Headquarters
Dreieich
Founded
1946
ISIN
DE0005227201
FIGI
BBG000BL3872
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs. It operates through the following segments: Therapy, Plasma and Services, and Other. The Therapy segment develops and produces blood plasma-based immunoglobulins, clotting factors, and albumins which are used to treat diseases of the immune system, haematological diseases, and in intensive care medicine. The Plasma and Services segment includes the areas of plasma sales and contract manufacturing. The Other segment refers to the merchandise business. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.

Check out other big names from the same industry as BIO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Biotest AG stocks are traded under the ticker BIO.
BIO reached its all-time high on Jan 7, 2022 with the price of 44.100 EUR, and its all-time low was 1.015 EUR and was reached on Apr 1, 2003. View more price dynamics on BIO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Biotest AG financials in yearly and quarterly reports right on TradingView.
BIO net income for the last quarter is ‪−21.40 M‬ EUR, while the quarter before that showed ‪−3.50 M‬ EUR of net income which accounts for −511.43% change. Track more Biotest AG financial stats to get the full picture.
Yes, BIO dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 0.10%. Tracking Biotest AG dividends might help you take more informed decisions.
Biotest AG dividend yield was 0.10% in 2024, and payout ratio reached 6.00%. The year before the numbers were 0.19% and 2.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 16, 2025, the company has ‪2.5 K‬ employees. See our rating of the largest employees — is Biotest AG on this list?
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biotest AG stock right from TradingView charts — choose your broker and connect to your account.